Acquired Hemophilia A successfully treated with rituximab by Giovanni D'Arena, Elvira Grandone, Matteo Nicola Dario Di Minno, Pellegrino Musto, Giovanni Di Minno

Get full text

New opportunities in Haemophilia treatment: Efmoroctocog Alfa for patients with Haemophilia A by Giovanna Elisa Calabrò, Giancarlo Castaman, Giovanni Di Minno, Silvia Coretti, Filippo Rumi, Jovana Stojanovic, Dario Sacchini, Carlo Favaretti, Americo Cicchetti

Get full text

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review by Mark T. Reding, Shadan Lalezari, Gili Kenet, Giovanni Di Minno, Jonathan Ducore, Alexander Solms, Anita Shah, Pål André Holme, Lone H. Poulsen, Karina Meijer, Mindy Simpson, Maria Elisa Mancuso

Get full text

Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review by Mark T. Reding, Shadan Lalezari, Gili Kenet, Giovanni Di Minno, Jonathan Ducore, Alexander Solms, Anita Shah, Pål André Holme, Lone H. Poulsen, Karina Meijer, Mindy Simpson, Maria Elisa Mancuso

Get full text

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies by Giovanni D’Arena, Candida Vitale, Marta Coscia, Agostino Festa, Nicola Matteo Dario Di Minno, Vincenzo De Feo, Michele Caraglia, Gioacchino Calapai, Luca Laurenti, Pellegrino Musto, Giovanni Di Minno, Daniela Fenoglio

Get full text